Vaccines Related News
The critical vaccine cold chain
Dr Nenad Miljković from the European Association of Hospital Pharmacists (EAHP) outlines the critical role of cold chain storage in maintaining the efficacy and...
mRNA vaccines: are they the way forward?
mRNA vaccine technology is broadening the scope of effective vaccine-based solutions that can mitigate the spread of harmful pathogens in infectious and non-infectious diseases.
For...
Defence Therapeutics granted US patent for vaccine enhancer technology
Discover how the issue of a patent will allow Defence Therapeutics' vaccine enhancer technology to be commercialised.
Time for Europe to prioritise preventative health
Vaccine confidence has fallen to pre-pandemic levels but, says Sibilia Quilici, Executive Director of Vaccines Europe, there is a need and value in boosting...
Defence Therapeutics’ mRNA cancer vaccine testing begins
Canadian biopharmaceutical specialist Defence Therapeutics has announced that testing of its revolutionary AccumTM-linked mRNA cancer vaccine has started.
The performance of Defence’s AccumTM mRNA cancer...
Challenges and opportunities for cervical screening and HPV vaccine uptake
Despite being one of the most preventable and treatable forms of cancer, many barriers to cervical cancer screening and HPV vaccine uptake exist. We...
Developing mRNA vaccine technology
Following the unprecedented development of vaccines during the COVID-19 pandemic, we spoke to Dinah Knotts about mRNA vaccine technology and what further opportunities it...
Clinical trial finds temperature-stable TB vaccine safe and effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it was safe.
A phase 1 trial, supported by the...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
NICE recommends three treatments for COVID-19
The National Institute for Health and Care Excellence (NICE) has recommended three treatments for COVID-19 that are cost-effective.
Everyone with COVID-19 at the highest risk...
Evusheld not recommended for vulnerable adults with COVID-19
NICE has not recommended Evusheld for vulnerable adults in England with COVID-19 due to a lack of evidence of its effectiveness.
Evusheld is used to...
Can the BCG vaccine combat cancer and autoimmune diseases?
Researchers have proposed that the 100-year-old BCG vaccine, originally used for tuberculosis, could be effective against cancer and autoimmune diseases.
At the beginning of the...
Defence Therapeutics begins manufacturing of it’s ARM vaccine
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the start...
The TB vaccine does not protect elderly patients from COVID-19
The TB vaccine does not protect the elderly against disease symptoms caused by COVID-19, according to researchers in the Netherlands.
These findings come from a...
74% of UK parents support routine chickenpox vaccine
Almost three-quarters of UK parents would support the chickenpox vaccine being added to the childhood vaccination schedule.
The chickenpox vaccine protects against the varicella-zoster virus...
Defence Therapeutics has melanoma vaccine validated
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
New discovery could lead Epstein-Barr virus vaccines
Researchers from MedUni Vienna have found a specific immune response to the virus Epstein-Barr virus that could help the development of new vaccines.
The research...
Defence Therapeutics launch Accum-mRNA vaccine programme
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the advancement...
COVID-19 infection and vaccination provide protection against omicron BA.5
A study from the University of Lisbon has shown that vaccination and previous COVID-19 infection grants protection against omicron BA.5.
The study was led by...
WHO update guidelines on HPV vaccination
The World Health Organization (WHO) has recently published a paper outlining updates to their recommendations for the human papillomavirus (HPV) vaccine.
Notably, the paper states...
